Findings from Analysis Group Inc. Provides New Data on Non-Small Cell Lung Cancer (Real-world Safety of First-line Immuno-oncology Combination Therapies for Advanced Non-small-cell Lung Cancer).

MLA

“Findings from Analysis Group Inc. Provides New Data on Non-Small Cell Lung Cancer (Real-World Safety of First-Line Immuno-Oncology Combination Therapies for Advanced Non-Small-Cell Lung Cancer).” Immunotherapy Weekly, Feb. 2024, p. 272. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175461906&authtype=sso&custid=ns315887.

APA

Findings from Analysis Group Inc. Provides New Data on Non-Small Cell Lung Cancer (Real-world Safety of First-line Immuno-oncology Combination Therapies for Advanced Non-small-cell Lung Cancer). (2024). Immunotherapy Weekly, 272.

Chicago

“Findings from Analysis Group Inc. Provides New Data on Non-Small Cell Lung Cancer (Real-World Safety of First-Line Immuno-Oncology Combination Therapies for Advanced Non-Small-Cell Lung Cancer).” 2024. Immunotherapy Weekly, February, 272. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175461906&authtype=sso&custid=ns315887.